Sirolimus-eluting DCB: update from the Eastbourne study
This video is supported by Concept Medical
Summary
In this short video, Bernado Cortese (Italy) describes the interim analysis of the Eastbourne study, which is evaluating the performance of a sirolimus-eluting DCB for the treatment of any type of coronary lesion, including native vessel disease and in-stent restenosis. The Eastbourne registry is enrolling patients and aiming for a target population of 2,000, which will be the largest DCB registry to date. Watch to find out how the device is faring in coronary arteries…
This interview supported by Concept Medical was filmed at EuroPCR 2019: see more videos here…